Get the content you want anytime you want.
REGISTER NOW | SIGN IN
ARTICLE

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

AUG 14, 2017 | JESSICA ROBINSON, PHARMD, BCPS; JAMIE WAGNER, PHARMD, BCPS; NICOLE BRANDT, PHARMD, MBA, BCPP, CGP, FASCP; AND ALAN GROSS, PHARMD, BCPS-AQ-ID
Antimicrobial resistance is a world­wide threat, resulting in more than 2 million infections and almost 25,000 deaths each year in the United States.1 Patients in long-term-care (LTC) facilities are considered to be at an increased risk of infection with multi­drug-resistant bacteria due to several factors. First, these patients generally have multiple comorbidities, making them more suscep­tible to infection. Second, patients in LTC facilities are also more likely to be exposed to an antimicrobial agent.2 Studies have shown that up to 70% of residents receive at least one course of systemic antibiotics per year, with 40% to 75% of those courses be­ing unnecessary or inappropriate.2,3 This in­creases not only the risk of colonization or infection because of a multidrug-resistant organism, but also the risk of antibiotic-associated adverse events, including Clostrid­ium difficile infection.2  

Summary of CDC Core Elements for Antibiotic Stewardship in Nursing Homes

Antimicrobial stewardship is now widely recognized as a key strategy to ensuring optimal patient outcomes while reducing the risk of antimicrobial resistance. In 2016, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America published new antimicrobial stewardship guidelines, endorsed by the Society of Infectious Diseases Pharmacists (SIDP) and others.3 These updated guidelines recommend employing antimicrobial stewardship strategies to decrease antimicrobial use throughout LTC facilities. Soon after these recommendations were released, the Centers for Medicare & Medicaid Services (CMS) published a final rule requiring LTC facilities to establish an antibiotic stewardship program by November 28, 2017. The rule states that the program should consist of antibiotic use protocols as well as a system to monitor antimicrobial use.


Advocacy and Research Foundation Partners
FEATURED
Big advances in treatment can